OptiMATE Gradient Maker Transforms Purification
Beckman Coulter has launched the OptiMATE Gradient Maker, an automation tool that accelerates density gradient ultracentrifugation.
Category: Specimen Collection & Handling
Specimen Collection & Handling
Latest
Specimen Collection & Handling
Latest
Babson Diagnostics’ New Blood Test Gets MedTech Breakthrough Award
Babson Diagnostics won a MedTech Breakthrough Award in the Best New Diagnostic Technology Solution category for its blood testing solution.
Specimen Collection & Handling
Latest
YourBio’s Blood Collection Device Gets Expanded Regulatory Approval
YourBio Health received further regulatory approval for its TAP Micro Select blood collection device with certification for CE Marking.
Tuberculosis Diagnosis Made Easy
Tuberculosis diagnosis usually requires coughing up a sputum sample from the lungs, but another way has been found to identify the disease.
Read More
Babson, BD Partnership to Advance Diagnostic Blood Collection in New Care Settings
Babson Diagnostics and BD announced the expansion of a strategic partnership to move blood sample collection into new care settings.
Read More
Implementing Dried Blood Spot (DBS) Testing in the Clinical Laboratory
Dried blood spot testing provides clinical labs an easy-to-collect, reliable, and cost-effective means to test for a variety of diseases.
Read More
Akoya Biosciences Launches Single-Cell Spatial Biology System
Akoya Biosciences has announced the commercial availability of the PhenoCycler-Fusion system for high-speed imaging of whole slides.
Read More
Saliva Testing Shows Promise for Patients with Psychiatric Disorders
Research points to saliva testing as a potential alternative to blood sampling for patients with bipolar disorder, schizophrenia, and depression.
Read More
Toxicology Testing: Addressing the Epidemic within the Pandemic
Timely toxicology testing remains vital to patient treatment, but the challenge is staying ahead of emerging illicit drugs.
Read More
National Drug Impaired Driving Testing Recommendations Released
An update to the NSC-ADID recommendations for toxicology testing in impaired driving and motor vehicle fatalities has just been released.
Read More
Salivary Protein Wiki May Transform Diagnostic Testing
To improve the development of new saliva-based diagnostic tests, the NIDCR has supported the development of the Human Salivary Proteome Wiki.
Read More
CDC Updates Guidelines for Collecting, Handling, Testing Clinical Specimens for Covid-19
The CDC has updated its Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for COVID-19 with language clarifications.
Read More
Spectrum Solutions Gets EUA for SDNA-1000 Saliva Collection Device
The self-contained saliva collection kit provides sample consistency while suspending and neutralizing viral RNA transcripts, completely inactivating the live covid-19 virus.
Read More
Cancer Detection and Liquid Biopsy
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read More
Renal Cell Carcinoma Liquid Biopsy Trial Underway
The AUR87A trial will involve 16 hospitals across Europe and the United States, making it the largest-ever prospective multicenter study of a diagnostic for the detection of recurrence after surgery in clear cell renal cell carcinoma.
Read MorePersonal Genome Diagnostics and Eisai Collaborate to Develop a Comprehensive Solution for Liquid Biopsy Biomarker Discovery
The collaboration intends to create a kitted next-generation sequencing product that will enable researchers and biopharma companies to conduct biomarker discovery, using noninvasive blood samples collected from patients in clinical trials.
Read MorePulmonary Fibrosis Foundation Provides Position Statement on Use of Surgical Lung Biopsy for Diagnosis of Pulmonary Fibrosis
The Pulmonary Fibrosis Foundation advises that surgical lung biopsy be considered only for patients who lack a confident clinical-radiographic diagnosis after the appropriate noninvasive evaluation.
Read More
MolDx Issues LCD for Decipher Prostate Biopsy Genomic Test
The Medicare LCD provides coverage for the Decipher prostate biopsy genomic test for men with both favorable and unfavorable intermediate-risk prostate cancer.
Read More